Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIN457 in active non-infectious uveitis
jRCT2080221051Phase 3
- Sponsor
- Novartis
- Start
- Mar 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of secukinumab in uveitis, sponsored by Novartis.
02
Drugs
secukinumab
03
Conditions
uveitis
Beyond the preview
Go deeper on jRCT2080221051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221051.